ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Basic/Clinical Science Session

Novel Therapeutic Approaches and Pathways for Phosphate and Fibroblast Growth Factor 23 Regulation

November 06, 2025 | 02:00 PM - 04:00 PM

Location: Room 370A, Convention Center

Session Description

Disordered mineral metabolism, including alterations in phosphate and fibroblast growth factor 23 (FGF23), are strongly associated with adverse outcomes in kidney diseases. Current treatment options are limited, in part because of incomplete understanding of the underlying physiology of phosphate and FGF23 regulation in health and disease. Emerging insights along these lines have the potential to identify new therapeutic opportunities relevant to AKI, CKD, and ESKD.

Learning Objective(s)

  • Describe how vitamin D regulation in the intestine can affect systemic mineral metabolism
  • Explain how systemic vs. bone effects of phosphate can be separated
  • Distinguish the role of phosphate in AKI and its complications
  • Describe the potential adverse role for calciprotein particles in CKD and ESKD

Learning Pathway(s)

  • Bones‚ Stones‚ and Mineral Metabolism

Moderators

Presentations